James Healy
Affiliations
- at Y-Mabs Therapeutics Inc. (YMAB), 2025-07-02
- at Rapport Therapeutics Inc. (RAPP), 2025-06-18
- at Bioage Labs Inc. (BIOA), 2025-06-09
- at Natera Inc. (NTRA), 2025-04-30
- at Bolt Biotherapeutics Inc. (BOLT), 2024-06-14
- at Karuna Therapeutics Inc. (KRTX), 2024-03-18
- Director at Arrivent Biopharma Inc. (AVBP), 2024-01-31
- Large Shareholder, Director at Cincor Pharma Inc. (CINC), 2023-02-28
- Large Shareholder at Vera Therapeutics Inc. (VERA), 2023-02-08
- Director at Coherus Biosciences Inc. (CHRS), 2022-02-11
- Large Shareholder at Aerovate Therapeutics Inc. (AVTE), 2021-06-29
- Large Shareholder at Checkmate Pharmaceuticals Inc. (CMPI), 2020-08-13
- Large Shareholder at Inozyme Pharma Inc. (INZY), 2020-07-28
- Large Shareholder at Akouos Inc. (AKUS), 2020-07-02
- Large Shareholder at Iterum Therapeutics Plc (ITRM), 2020-06-04
- Large Shareholder at Nextcure Inc. (NXTC), 2019-11-20
- Large Shareholder at Galera Therapeutics Inc. (GRTX), 2019-11-12
- Large Shareholder at Entasis Therapeutics Holdings Inc. (ETTX), 2018-10-03
- Large Shareholder at Principia Biopharma Inc. (PRNB), 2018-09-20
- Director at Edge Therapeutics Inc. (EDGE), 2017-06-21
- Large Shareholder at Marinus Pharmaceuticals Inc (MRNS), 2016-10-24
- Director at Amarin Corp Plc (AMRN), 2016-07-13
- Large Shareholder at Aclaris Therapeutics Inc. (ACRS), 2015-10-13
- Large Shareholder at Mirna Therapeutics Inc. (MIRN), 2015-10-06
- Large Shareholder at Atyr Pharma Inc (LIFE), 2015-05-15
- Large Shareholder, Director at Hyperion Therapeutics Inc (HPTX), 2015-05-09
- Large Shareholder at Spark Therapeutics Inc. (ONCE), 2015-01-30
- Large Shareholder at Histogenics Corp (HSGX), 2014-12-10
- Director at Intermune Inc (ITMN), 2014-10-02
- Large Shareholder at Alimera Sciences Inc (ALIM), 2014-09-15
- Large Shareholder at Aerie Pharmaceuticals Inc (AERI), 2014-07-12
- Large Shareholder at Versartis Inc. (VSAR), 2014-03-28
- Large Shareholder at Ocera Therapeutics Inc. (OCRX), 2014-03-20
- at Anthera Pharmaceuticals Inc (ANTH), 2013-05-20
- Director at Kalobios Pharmaceuticals Inc (KBIO), 2013-05-03
- Large Shareholder, Director at Durata Therapeutics Inc. (DRTX), 2012-07-25
- Large Shareholder at Trius Therapeutics Inc (TSRX), 2012-01-17
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| BIOA | $18.00 | 26,497 | $476,946.00 | 26,497 | 2024-09-27 | Filing |
| BIOA | $18.00 | 21,814 | $392,652.00 | 21,814 | 2024-09-27 | Filing |
| BIOA | $18.00 | 18,353 | $330,354.00 | 18,353 | 2024-09-27 | Filing |
| BIOA | $18.00 | 11,113 | $200,034.00 | 11,113 | 2024-09-27 | Filing |
| BIOA | $18.00 | 588,888 | $10,599,984.00 | 2,227,124 | 2024-09-27 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| NTRA | $58.75 | 644,000 | $37,835,000.00 | 0 | 2023-12-13 | Filing |
| CINC | $14.32 | 6,000 | $85,920.00 | 0 | 2022-11-28 | Filing |
| NTRA | $37.71 | 2,400 | $90,498.00 | 0 | 2022-11-16 | Filing |
| KRTX | $199.90 | 6,027 | $1,204,770.78 | 0 | 2023-01-13 | Filing |
| CHRS | $16.12 | 286,076 | $4,611,545.12 | 0 | 2021-09-29 | Filing |